University of Missouri School of Medicine MU Health School of Medicine
News Divider
Loading video...

Compound in Grapes, Red Wine Could Help Treat Multiple Types of Cancer, Study Finds


Resveratrol might provide extra punch to cancer cells during treatment

A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment. This research, which studied melanoma cells, follows a previous MU study that found similar results in the treatment of prostate cancer. The next step is for researchers to develop a successful method to deliver the compound to tumor sites and potentially treat many types of cancers.

Nicholl
Nicholl

"Our study investigated how resveratrol and radiotherapy inhibit the survival of melanoma cells," said Michael Nicholl, MD, assistant professor of surgery at the MU School of Medicine and surgical oncologist at Ellis Fischel Cancer Center in Columbia, Mo. "This work expands upon our previous success with resveratrol and radiation in prostate cancer. Because of difficulties involved in delivery of adequate amounts of resveratrol to melanoma tumors, the compound is probably not an effective treatment for advanced melanoma at this time."

The study found that melanoma cells become more susceptible to radiation if they were treated first with resveratrol. The MU researcher found that when the cancer was treated with resveratrol alone, 44 percent of the tumor cells were killed. When the cancer cells were treated with a combination of both resveratrol and radiation, 65 percent of the tumor cells died.

Nicholl said his findings could lead to more research into the cancer-fighting benefits of the naturally occurring compound.

"We've seen glimmers of possibilities, and it seems that resveratrol could potentially be very important in treating a variety of cancers," Nicholl said. "It comes down to how to administer the resveratrol. If we can develop a successful way to deliver the compound to tumor sites, resveratrol could potentially be used to treat many types of cancers. Melanoma is very tricky due to the nature of how the cancer cells travel throughout the body, but we envision resveratrol could be combined with radiation to treat symptomatic metastatic tumors, which can develop in the brain or bone."

Resveratrol supplements are available over the counter in many health food sections at grocery stores. Nicholl does not recommend that patients rely on resveratrol supplements to treat cancer because more research is needed.

Nicholl's study was published in the Journal of Surgical Research, the journal for the Association for Academic Surgery. If additional studies are successful within the next few years, MU officials will request authority from the federal government to begin human drug development. This is commonly referred to as the "investigative new drug" status. After this status has been granted, researchers may conduct clinical trials with the hope of developing new treatments for cancer.






News and Events

Hwang Key Component in Protein that Causes Cystic Fibrosis Identified
Findings may lay foundation for the development of medications

SOM Graduation 2015 MU School of Medicine to Award 101 Medical Degrees at Commencement
Forty-five will remain in Missouri for specialty training in residency

George Kracke Potential New Painkiller Provides Longer Lasting Effects
Early studies show promise for alternative type of anesthetic

Durante Enzyme Responsible for Obesity-Related Hypertension Identified
Discovery may lead to new treatment options for arterial disease caused by obesity

Family Medicine AAFP Award MU Family Medicine Ranked Among Nation’s Best by AAFP
Medical school in top 10 for helping build family physician workforce

Legacy Teachers Medical Students Thank Legacy Teachers
MU’s unique program celebrates patients’ role in teaching future physicians

58th Alumni awards Eight Graduates and Supporters Receive 58th Annual Alumni Awards
Syed Arshad Husain presented with top honor

St. Baldricks Participants Go Bald for Childhood Cancer Research
Community donates more than $33,000 to the cause

Teresa Lever, MD New Model Could Help Identify Root Cause of Swallowing Disorder
Findings may ‘change the landscape’ of dysphagia intervention


Medzou Golf Tournament Spend a Day on the Greens to Fund a Free Community Health Clinic
Money raised helps MedZou clinic care for uninsured mid-Missourians

Laine Young-Walker, MD Bridging the Gap in Psychiatric Care for Children
MU School of Medicine program expands access in Boone County




Media Relations
University of Missouri Health System
One Hospital Drive, DC028.00
Columbia, MO 65212
24/7 on-call pager: (573) 876-0708

Mary Jenkins
jenkinsmg@health.missouri.edu
(573) 882-7299

Jeff Hoelscher
hoelscherj@health.missouri.edu
(573) 884-1608

Derek Thompson
thompsonder@health.missouri.edu
(573) 882-3323

Justin Kelley (Photographer)
kelleyju@health.missouri.edu
(573) 882-5786
Pager (573) 397-9289


Web Communications
University of Missouri Health System
One Hospital Drive, MA204G, DC018.00
Columbia, MO 65212
(573) 884-0298

Rich Gleba
glebar@health.missouri.edu
(573) 884-0298

Laura Gerding, APR
gerdingla@health.missouri.edu
(573) 882-9193

Velvet Hasner
hasnerv@health.missouri.edu
(573) 884-1115



Printer Friendly
Follow us on Twitter!   Facebook   YouTube Videos   Instagram   Pinterest  
Website created and maintained by the Office of Communications. Contact the MU School of Medicine.
Revised: January 03, 2014 - Copyright © 2014 - Curators of the University of Missouri. All rights reserved. DMCA and other copyright information. An equal opportunity/access/affirmative action/pro-disabled and veteran employer.